BIOSECURE Nudges Celltrion’s Jump Into CDMO Business

New Drug Development, Other plans

 
• By Jung Won Shin
  
Celltrion Group Chairman Jungjin Seo
CDMO Subsidiary May Begin To Generate Sales From 2028

More from South Korea

More from Business